Ardelyx reported $128.02M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Amgen USD 6.22B 34M Jun/2026
Ardelyx USD 128.02M 110.29M Mar/2026
aTyr Pharma USD 2.79M 67.83K Mar/2026
Corcept Therapeutics USD 13.18M 295K Jun/2026
Sanofi EUR 23.5B 812M Mar/2026
TG Therapeutics USD 147.97M 18.94M Jun/2026
United Therapeutics USD 193.8M 15.5M Jun/2026